Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) disclosed a repurchase of 132,000 H-shares on 29 April 2026, paying a total of HKD 0.47 million at prices ranging from HKD 3.52 to HKD 3.55 per share (average HKD 3.54).

Following the transaction: • Issued shares (excluding treasury) fell by 0.003 % to 4,468.77 million. • Treasury share balance increased to 53.56 million. • Total issued share capital remained unchanged at 4,522.33 million.

The repurchase was conducted under the mandate approved on 27 May 2025, which authorises the company to buy back up to 451.56 million shares. Cumulative repurchases under this mandate now stand at 46.91 million shares, representing 10.39 % of the share count on the mandate date.

A moratorium on new share issues or sales of treasury shares is in effect until 30 May 2026, in accordance with Hong Kong Stock Exchange regulations.